Your browser does not support javascript! Please enable it, otherwise web will not work for you.

Penumbra, Inc. builds minimally invasive medical devices for neurovascular and peripheral vascular conditions—such as aspiration thrombectomy and embolization systems—and rehabilitation technologies. It designs, manufactures, and sells to hospitals and healthcare providers via direct sales in the U.S., EU, Canada, and Australia and through distributors elsewhere. Founded in 2004 and headquartered in Alameda, California, Penumbra is a public company listed on the NYSE.